Skip to main content
Equibles

OPTH · Optimi Health Corp.

Track OPTH — free

Use OPTH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OPTH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.53 +0.17 (+5.06%) At close · Oct 21
Rebalance outlook locked
Market Cap
$19.24M
Shares
5.73M
Volume · Oct 21 18.73K Avg daily vol (3M) 39.03K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.53 Open$3.49 Day$3.27–3.58 Available close range$3.17–6.08 Avg vol 30d45K Short int29K · 0.5% float · 1.0d Short vol34% DataMay 2026–Oct 2026

The closing range uses available history since May 20, 2026; less than a full year is stored.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.5%
Latest settlement · 1.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 16.7 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −22%
below
RSI (14) 34
neutral
MACD trend Negative
52-week position 13%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
2 of 10 funds reported for Sep 30 · net +33 sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.51% of float · ▲ +43.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
10 holders — 13F breadth
Squeeze score 38
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 87%
annualized · 1-yr
Max drawdown −48%
past year
ATR 9.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−22% Bearish
RSI (14)
34 Neutral
MACD trend
Negative Bearish
52-week position
13% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
2 of 10 funds reported for Sep 30 · net +33 sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.51% of float · ▲ +43.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
10 holders — 13F breadth
Price context
position in its available closing range
Range low $3 Now $4 · 13% Range high $6
vs 50-day avg -22%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OPTH
Optimi Health Corp.
this stock
$19.24M — — — 0.5%
TAK
Takeda Pharmaceutical Co Ltd
 $64.15B +27.8% — — 0.1%
GALDY
Galderma Group AG
 $49.23B +1.9% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $46.21B +30.2% +4.3% 65.0 2.6%
HLN
Haleon plc
 $44.06B -0.9% — — 0.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
11
% held
7.7%
Reported
2 of 10
Top holder
Yorkville Advisors Global…
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Rising
Shares short
29.5K
Days to cover
1.0d
Change
+9.0K sh
View
Short Volume
Short vol %
34%
As of
Oct 21, 2026
Short Total
View
Fails to Deliver
FTD shares
2.0K
Value
$10.0K
As of
Sep 24, 2026
View
Off-Exchange
Off-exchange %
53.7%
Week of
Sep 14, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 20, 2026
This year
31

Optimi Health Corp. completed an MDMA production batch for a proposed Canadian Phase 3 PTSD trial enrolling up to 100 participants, a MAPS Israel trial, and an Australian commercial export planned before the end of 2026; the Canadian trial is expected to begin in 2027.

View
Exempt Offerings
Offering
$321.2K
Filed
Aug 26, 2024
View

Performance

5D 20D 120D MTD YTD
OPTH +11.5% -28.8% — -25.1% —
SPY +0.5% +0.7% +7.6% +1.4% +13.4%
vs SPY +11.1% -29.5% — -26.4% —
Key facts CIK 2027329 CUSIP 68405H308 13F (30d) 2 filings 2 filers Visit website Investor relations